Abstract:Across the entire spectrum of estimated glomerular filtration rate (eGFR), natriuresis‐guided therapy improved 24 h natriuresis and diuresis, even in patients with low eGFR. Although there was more (pseudo) worsening renal function (WRF) with natriuresis‐guided therapy, the difference in drop‐in eGFR was transient and modest. Natriuresis‐guided diuretic treatment is effective across the entire spectrum of eGFR and is not associated with excess renal risk. CI, confidence interval; HF, heart failure; HR, hazard ratio; SOC, standard of care. Aim In a randomized controlled trial, we recently showed that a natriuresis‐guided diuretic approach improved natriuresis and diuresis in patients with acute heart failure (HF). In this pre‐specified analysis, we investigated the association between (worsening) renal function, outcomes and the effect of intensive natriuresis‐guided loop diuretic therapy as compared with standard of care. Methods and results The Pragmatic Urinary Sodium‐based algoritHm in Acute Heart Failure (PUSH‐AHF) trial randomized patients to natriuresis‐guided diuretic therapy or standard of care. Serum creatinine and estimated glomerular filtration rate (eGFR) were assessed at fixed timepoints, and worsening renal function (WRF) was assessed at 72 h. The primary outcome was the interaction between randomized treatment allocation, baseline eGFR and the dual primary outcome of PUSH‐AHF: total natriuresis at 24 h and time to all‐cause mortality or HF rehospitalization at 180 days. In 309 patients, median baseline eGFR was 53 (35–73) ml/min/1.73 m2, and 58% had eGFR <60 ml/min/1.73 m2. Baseline eGFR did not significantly modify the treatment effect of natriuresis‐guided diuretic therapy on natriuresis at 24 h (p for interaction = 0.730). However, baseline eGFR significantly modified the effect on all‐cause mortality and HF rehospitalization (p for interaction = 0.017): the risk of this second primary outcome was lower in patients with lower eGFR who were randomized to the natriuresis‐guided group. In the natriuresis‐guided arm, eGFR decreased more (−11.0 vs. −6.91 ml/min/1.73 m2; p = 0.002) during the first 3 days, but this effect was attenuated at discharge (−10.3 vs. −8.69 ml/min/1.73 m2; p = 0.38). WRF was more frequently observed in patients randomized to natriuresis‐guided treatment, but was not associated with worse clinical outcomes. Conclusions Natriuresis‐guided diuretic treatment improved diuresis and natriuresis irrespective of baseline eGFR and occurrence of WRF, was effective even in patients with low eGFR, and the observed effect on eGFR was transient and not associated with worse clinical outcomes.

The role of urine sodium in acutely decompensated heart failure

Spot urine sodium as a marker of urine dilution and decongestive abilities in acute heart failure

Spot urine sodium‐to‐creatinine ratio surpasses sodium in identifying poor diuretic response in acute heart failure

The utility of urine sodium–guided diuresis during acute decompensated heart failure

The dynamics of urine sodium concentration after intra-venous furosemide in patients with acute heart failure

Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload

Diuretic resistance in acute heart failure: proposal for a new urinary sodium-based definition

Utility of Urine Biomarkers and Electrolytes for the Management of Heart Failure

Sodium loading in ambulatory patients with heart failure with reduced ejection fraction: Mechanistic insights into sodium handling

Targeting Sodium in Heart Failure

A review regarding the article 'Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure'

Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial

Renal Sodium Avidity in Heart Failure

Nurse-led diuretic titration via a point-of-care urinary sodium sensor in patients with acute decompensated heart failure (EASY-HF): A single-centre, randomized, open-label study

Urinary composition during decongestive treatment in heart failure with reduced ejection fraction

Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload

Urine chloride trajectory and relationship with diuretic response in acute heart failure

Prognostic value of glomerular filtration changes versus natriuretic response in decompensated heart failure with reduced ejection

Predictors of Long-Term Mortality in Patients with Acute Heart Failure.

Worsening renal function in acute heart failure in the context of diuretic response

Renal function and natriuresis‐guided diuretic therapy – a pre‐specified analysis from the PUSH‐AHF trial